Myopia Control In Markham Ontario
What is Myopia?
Why is myopia a concern?
Why manage myopia in children? |
Myopia progresses fastest in younger children, especially those under age 10. 5 This means that the most important opportunity to slow eye growth is when children are younger. Myopia management aims to apply specific treatments to slow the excessive eye growth to a lesser rate. Experts agree that myopia management should be commenced for all children under age 12, 6 and typically continue into the late teens. 7
The short-term benefit of slowing myopia progression is that a child’s prescription will change less quickly, giving them clearer vision for longer between eye examinations. The long-term benefit is reducing the lifetime risk of eye disease and vision impairment. This risk increases as myopia does 3 with the good news being that reducing the final level of myopia by only 1 dioptre reduces the lifetime risk of myopic macular degeneration by 40% and the risk of vision impairment by 20%. 8 |
Treatments for slowing myopia progression
The best option for your child will depend on their current prescription and other vision and eye health factors determined in their eye examination. Your eye care practitioner will discuss the options with you to determine the best option. Treatment options vary across the world due to availability, supply and regulatory reasons. It is important to note that no treatment can promise the ability to stop myopia progression in children, only to slow it down.
Contact lenses
Risks and safety
Contact lens wear increases the risk of eye infection compared to wearing spectacles, with the risks being:
1 per 1,000 wearers per year for reusable soft contact lenses or overnight orthokeratology lenses 9,10
1 per 5,000 wearers per year for daily disposable soft contact lenses 9
With proper hygiene and maintenance procedures, this risk can be well managed – especially by avoiding any contact of water with contact lenses or accessories. 11 Other side effects of contact lenses to control myopia can be temporary adaptation to the different experience of vision, which typically resolves in 1-2 weeks.
Benefits
There are many benefits to children wearing contact lenses:
1. Wearing contact lenses improves children’s self confidence in school and sport, and their satisfaction with their vision – as much as it does for teens 12
2. Children aged 8-12 years appear to be safer contact lens wearers than teens and adults, with a lower risk of eye infection 13
3. Children only take 15 minutes more to learn how to handle contact lenses than teens 14
Soft myopia controlling contact lenses are worn during waking hours. They may be daily disposable, or reusable for up to a month. They typically require more appointments for fitting than spectacles but less than orthokeratology. Adaptation to the lens-on-eye feeling typically occurs in a few days. There are benefits in safety with daily disposables being the safest modality, and the number of lenses retained meaning loss or breakage is less of a practical issue.
Treatments
(Click a treatment to see how it works)
1. Ortho Keratology (Ortho-K) Lenses
2. Soft Myopia Control Contact Lenses
3. Low-dose Atropine Eye Drops
4. Myopia Control Spectacles
⚠️ Medication Safety: Atropine drops must be stored securely. While safe for eye application, ingestion can be dangerous for young children. [Ref 16]
Spectacles
Suggested shorter reference list for parents
https://pubmed.ncbi.nlm.nih.gov/26875007/
https://pubmed.ncbi.nlm.nih.gov/24159085/
https://pubmed.ncbi.nlm.nih.gov/22772022/
https://pubmed.ncbi.nlm.nih.gov/27768171/
https://pubmed.ncbi.nlm.nih.gov/27350183/
https://pubmed.ncbi.nlm.nih.gov/33253901/
https://pubmed.ncbi.nlm.nih.gov/30817832/
https://pubmed.ncbi.nlm.nih.gov/31116165/
https://pubmed.ncbi.nlm.nih.gov/18538404/
https://pubmed.ncbi.nlm.nih.gov/23892491/
https://pubmed.ncbi.nlm.nih.gov/30789440/
https://pubmed.ncbi.nlm.nih.gov/17993828/
https://pubmed.ncbi.nlm.nih.gov/28514244/
https://pubmed.ncbi.nlm.nih.gov/17873776/
https://pubmed.ncbi.nlm.nih.gov/30514630/
https://pubmed.ncbi.nlm.nih.gov/2958765/
https://pubmed.ncbi.nlm.nih.gov/32674999/